OpenSAFELY codelists
- OpenPrescribing Measure: Co-amoxiclav, cephalosporins and quinolones (numerato dm+d
-
List of "broad-spectrum" antibiotics used by the following OpenPrescribing measures based on NICE guidance note KTT9:
- Opioid-containing medicines (buccal, nasal and oromucosal- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via buccal, nasal, or oromuscosal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (buccal, nasal and oromucosal- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via buccal, nasal, or oromuscosal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (inhalation- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via inhaled route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (inhalation- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via inhaled route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (oral - excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via oral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (oral - excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via oral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (parenteral- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via parenteral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (parenteral- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via parenteral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (rectal - excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via rectal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (rectal - excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via rectal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (transdermal- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via transdermal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (transdermal- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via transdermal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Orthopaedic Procedure Codes (OPCS-4) - Spinal Cord + roots SC OPCS-4
- Orthopaedic Procedure OPCS Codes All Spines OPCS-4